Apotheek Waelput: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek Waelput
Largest movements
- Receivables within one year +€739,666
up €739,666 (+119%), from €619,954 to €1.4m
of which Other amounts receivable: +€470,260
- Receivables after one year -€409,905
down €409,905 (-100%), from €409,905 to €0
- Reserves +€226,873
up €226,873 (+26.4%), from €858,564 to €1.1m
of which Distributable reserves: +€226,873
- Trade debts +€110,217
up €110,217 (+19.0%), from €580,877 to €691,094
- Tax, wage and social debts +€42,080
up €42,080 (+48.2%), from €87,314 to €129,394
of which Remuneration and social security: +€43,083
- Debts after one year -€40,306
down €40,306 (-78.4%), from €51,424 to €11,119
- Current portion of long-term debt -€28,219
down €28,219 (-32.3%), from €87,272 to €59,053
- Gross operating margin +€225,268
up €225,268 (+53.9%), from €418,193 to €643,461
- Staff costs +€115,682
up €115,682 (+61.5%), from €188,069 to €303,751
- Financial income -€30,680
down €30,680 (-71.6%), from €42,872 to €12,192
of which Non-recurring financial income: -€27,158
- Taxes +€20,646
up €20,646 (+25.6%), from €80,722 to €101,368
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,741,647 | €2,059,565 | +€317,918 | +18.3% |
| Fixed assets | 21/28 | €367,011 | €364,270 | -€2,741 | -0.7% |
| Tangible fixed assets | 22/27 | €96,149 | €86,167 | -€9,982 | -10.4% |
| Plant, machinery and equipment | 23 | €53,973 | €47,154 | -€6,819 | -12.6% |
| Furniture and vehicles | 24 | €29,913 | €29,083 | -€830 | -2.8% |
| Other tangible fixed assets | 26 | €12,263 | €9,930 | -€2,333 | -19.0% |
| Financial fixed assets | 28 | €270,863 | €278,104 | +€7,241 | +2.7% |
| Current assets | 29/58 | €1,374,636 | €1,695,294 | +€320,659 | +23.3% |
| Amounts receivable after more than one year | 29 | €409,905 | €0 | -€409,905 | -100% |
| Other amounts receivable | 291 | €409,905 | €0 | -€409,905 | -100% |
| Stocks and contracts in progress | 3 | €164,731 | €149,074 | -€15,656 | -9.5% |
| Stocks | 30/36 | €164,731 | €149,074 | -€15,656 | -9.5% |
| Amounts receivable within one year | 40/41 | €619,954 | €1,359,620 | +€739,666 | +119% |
| Trade receivables | 40 | €467,106 | €736,512 | +€269,405 | +57.7% |
| Other amounts receivable | 41 | €152,848 | €623,108 | +€470,260 | +308% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €170,187 | €177,617 | +€7,430 | +4.4% |
| Deferred charges and accrued income | 490/1 | €9,859 | €8,983 | -€876 | -8.9% |
| Total equity and liabilities | 10/49 | €1,741,647 | €2,059,565 | +€317,918 | +18.3% |
| Equity | 10/15 | €920,064 | €1,146,937 | +€226,873 | +24.7% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Reserves | 13 | €858,564 | €1,085,437 | +€226,873 | +26.4% |
| Non-distributable reserves | 130/1 | €6,150 | €6,150 | = | 0.0% |
| Legal reserve | 130 | €6,150 | €6,150 | = | 0.0% |
| Distributable reserves | 133 | €852,414 | €1,079,287 | +€226,873 | +26.6% |
| Amounts payable | 17/49 | €821,583 | €912,628 | +€91,044 | +11.1% |
| Amounts payable after more than one year | 17 | €51,424 | €11,119 | -€40,306 | -78.4% |
| Financial debts | 170/4 | €51,424 | €11,119 | -€40,306 | -78.4% |
| Amounts payable within one year | 42/48 | €767,609 | €901,509 | +€133,900 | +17.4% |
| Current portion of amounts payable after more than one year | 42 | €87,272 | €59,053 | -€28,219 | -32.3% |
| Financial debts | 43 | €7,620 | €7,630 | +€10 | +0.1% |
| Credit institutions | 430/8 | €7,620 | €7,630 | +€10 | +0.1% |
| Trade debts | 44 | €580,877 | €691,094 | +€110,217 | +19.0% |
| Suppliers | 440/4 | €580,877 | €691,094 | +€110,217 | +19.0% |
| Taxes, remuneration and social security | 45 | €87,314 | €129,394 | +€42,080 | +48.2% |
| Taxes | 450/3 | €51,423 | €50,420 | -€1,003 | -2.0% |
| Remuneration and social security | 454/9 | €35,890 | €78,974 | +€43,083 | +120% |
| Other amounts payable | 47/48 | €4,526 | €14,338 | +€9,811 | +217% |
| Accrued charges and deferred income | 492/3 | €2,550 | €0 | -€2,550 | -100% |
| Remuneration, social security and pensions | 62 | €188,069 | €303,751 | +€115,682 | +61.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,451 | €13,407 | +€1,957 | +17.1% |
| Other operating charges | 640/8 | €2,421 | €2,289 | -€131 | -5.4% |
| Gross operating margin | 9900 | €418,193 | €643,461 | +€225,268 | +53.9% |
| Operating profit (loss) | 9901 | €216,253 | €324,013 | +€107,760 | +49.8% |
| Financial income | 75/76B | €42,872 | €12,192 | -€30,680 | -71.6% |
| Recurring financial income | 75 | €15,713 | €12,192 | -€3,521 | -22.4% |
| Non-recurring financial income | 76B | €27,158 | €0 | -€27,158 | -100% |
| Financial charges | 65/66B | €9,230 | €7,963 | -€1,266 | -13.7% |
| Recurring financial charges | 65 | €9,230 | €7,963 | -€1,266 | -13.7% |
| Profit (loss) for the period before taxes | 9903 | €249,895 | €328,241 | +€78,347 | +31.4% |
| Income taxes | 67/77 | €80,722 | €101,368 | +€20,646 | +25.6% |
| Profit (loss) for the period | 9904 | €169,172 | €226,873 | +€57,701 | +34.1% |
| Profit (loss) for the period to be appropriated | 9905 | €169,172 | €226,873 | +€57,701 | +34.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.